GL1X · GenesisL1 explorer

MolNFT v1 · #161400 · protein

Leishmania major N-myristoyltransferase in complex with thienopyrimidine inhibitor imp-0000105

6QDD · Glycylpeptide N-tetradecanoyltransferase: “Leishmania major N-myristoyltransferase in complex with thienopyrimidine inhibitor imp-0000105”. X-ray diffraction, 3 ligands (MYA, HXW, MG), 2 pockets (best druggability 0.79). MolNFT v1…

PDB
6QDD
Type
protein
Length
411 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycylpeptide N-tetradecanoyltransferase
EC
2.3.1.97
UniProt
Q4Q5S8
Ligands
MYA, HXW, MG
Pockets
2 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycylpeptide N-tetradecanoyltransferase (EC 2.3.1.97)protein41133% helix, 27% strandQ4Q5S8

Ligands and binding sites

  • MYA · Tetradecanoyl-coa · ligand · chains A
  • HXW · 2-[(2~{S})-1-[2-[methyl-(1-methylpiperidin-4-yl) amino]thieno[3,2-d]pyrimidin-4-yl]-2,3-dihydropyrrol-2-yl]ethanenitrile · ligand · chains A
  • MG · Magnesium ion · metal · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19220.790.8179MYA, DMS, MG, HXW
21400.430.7526empty

Compared structures

  • 6QDD · Leishmania major N-myristoyltransferase in complex with thienopyrimidine inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.